1. Home
  2. OPK vs AOD Comparison

OPK vs AOD Comparison

Compare OPK & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • AOD
  • Stock Information
  • Founded
  • OPK 2007
  • AOD 2006
  • Country
  • OPK United States
  • AOD United Kingdom
  • Employees
  • OPK N/A
  • AOD N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • AOD Investment Managers
  • Sector
  • OPK Health Care
  • AOD Finance
  • Exchange
  • OPK Nasdaq
  • AOD Nasdaq
  • Market Cap
  • OPK 1.1B
  • AOD 862.4M
  • IPO Year
  • OPK 1995
  • AOD N/A
  • Fundamental
  • Price
  • OPK $1.19
  • AOD $8.79
  • Analyst Decision
  • OPK Buy
  • AOD
  • Analyst Count
  • OPK 4
  • AOD 0
  • Target Price
  • OPK $2.75
  • AOD N/A
  • AVG Volume (30 Days)
  • OPK 2.8M
  • AOD 423.5K
  • Earning Date
  • OPK 07-31-2025
  • AOD 01-01-0001
  • Dividend Yield
  • OPK N/A
  • AOD 12.95%
  • EPS Growth
  • OPK N/A
  • AOD 213.63
  • EPS
  • OPK N/A
  • AOD 1.93
  • Revenue
  • OPK $664,029,000.00
  • AOD $72,962,082.00
  • Revenue This Year
  • OPK N/A
  • AOD N/A
  • Revenue Next Year
  • OPK $6.98
  • AOD N/A
  • P/E Ratio
  • OPK N/A
  • AOD $4.44
  • Revenue Growth
  • OPK N/A
  • AOD N/A
  • 52 Week Low
  • OPK $1.11
  • AOD $6.99
  • 52 Week High
  • OPK $2.04
  • AOD $9.14
  • Technical
  • Relative Strength Index (RSI)
  • OPK 29.73
  • AOD 40.98
  • Support Level
  • OPK $1.34
  • AOD $8.91
  • Resistance Level
  • OPK $1.38
  • AOD $9.05
  • Average True Range (ATR)
  • OPK 0.06
  • AOD 0.09
  • MACD
  • OPK -0.02
  • AOD -0.03
  • Stochastic Oscillator
  • OPK 23.53
  • AOD 4.03

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

Share on Social Networks: